These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 10369622)
1. Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Hovinga CA; Chicella MF; Rose DF; Eades SK; Dalton JT; Phelps SJ Ann Pharmacother; 1999 May; 33(5):579-84. PubMed ID: 10369622 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Malamiri RA; Ghaempanah M; Khosroshahi N; Nikkhah A; Bavarian B; Ashrafi MR Eur J Paediatr Neurol; 2012 Sep; 16(5):536-41. PubMed ID: 22326977 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children. Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures. Yu KT; Mills S; Thompson N; Cunanan C Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474 [TBL] [Abstract][Full Text] [Related]
6. Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus. Sathe AG; Mishra U; Ivaturi V; Brundage RC; Cloyd JC; Elm JJ; Chamberlain JM; Silbergleit R; Kapur J; Lowenstein DH; Shinnar S; Cock HR; Fountain NB; Babcock L; Coles LD J Clin Pharmacol; 2021 Jun; 61(6):763-768. PubMed ID: 33336359 [TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients. Van Matre ET; Cook AM Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients. Taylor LM; Farzam F; Cook AM; Lewis DA; Baumann RJ; Kuhn RJ Pharmacotherapy; 2007 Apr; 27(4):519-25. PubMed ID: 17381378 [TBL] [Abstract][Full Text] [Related]
9. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy. Cloyd JC; Dutta S; Cao G; Walch JK; Collins SD; Granneman GR; Epilepsy Res; 2003 Feb; 53(1-2):19-27. PubMed ID: 12576164 [TBL] [Abstract][Full Text] [Related]
10. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study. Chen WB; Gao R; Su YY; Zhao JW; Zhang YZ; Wang L; Ren Y; Fan CQ Eur J Neurol; 2011 Dec; 18(12):1391-6. PubMed ID: 21557791 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762 [TBL] [Abstract][Full Text] [Related]
12. A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus. Brigo F; Igwe SC; Nardone R; Tezzon F; Bongiovanni LG; Trinka E Epileptic Disord; 2013 Sep; 15(3):314-23. PubMed ID: 23981687 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of continuous intravenous infusion of sodium valproate and midazolam on management of status epilepticus in children. Abbaskhanian A; Sheidaee K; Charati JY Arch Pediatr; 2021 Nov; 28(8):696-701. PubMed ID: 34706856 [TBL] [Abstract][Full Text] [Related]
14. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. McTague A; Kneen R; Kumar R; Spinty S; Appleton R Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010 [TBL] [Abstract][Full Text] [Related]
16. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Misra UK; Kalita J; Patel R Neurology; 2006 Jul; 67(2):340-2. PubMed ID: 16864836 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and clinical effect of phenobarbital in children with severe falciparum malaria and convulsions. Kokwaro GO; Ogutu BR; Muchohi SN; Otieno GO; Newton CR Br J Clin Pharmacol; 2003 Oct; 56(4):453-7. PubMed ID: 12968992 [TBL] [Abstract][Full Text] [Related]
18. Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China. Su Y; Liu G; Tian F; Ren G; Jiang M; Chun B; Zhang Y; Zhang Y; Ye H; Gao D; Chen W CNS Drugs; 2016 Dec; 30(12):1201-1207. PubMed ID: 27878767 [TBL] [Abstract][Full Text] [Related]
19. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician. Dutta S; Reed RC J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100 [TBL] [Abstract][Full Text] [Related]
20. Status epilepticus in children and adults. Lacey DJ J Clin Psychiatry; 1988 Dec; 49 Suppl():33-6. PubMed ID: 3058685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]